Baicalein (Flavonoid)

Baicalein is a bioactive flavonoid compound primarily extracted from Scutellaria baicalensis (Chinese skullcap) root. It demonstrates antioxidant properties through inhibition of oxygen radical formation and shows preliminary anti-cancer effects by inhibiting ornithine decarboxylase enzyme activity.

Origin & History

Baicalein is a trihydroxyflavone flavonoid (C15H10O5) with hydroxy groups at positions 5, 6, and 7, primarily extracted from the roots of Scutellaria baicalensis (Chinese skullcap) in the Lamiaceae family. It is produced via a specialized 4′-deoxyflavone biosynthetic pathway in plant roots, involving enzymes that convert chrysin to baicalein, and is typically extracted using ethanol or methanol solvents.

Historical & Cultural Context

Baicalein, as a major flavonoid in Scutellaria baicalensis roots, has been used in Traditional Chinese Medicine preparations for anti-inflammatory, antibacterial, antiviral, and antitumor purposes. It appears in formulations like PC-SPES, though specific historical timelines for baicalein isolation are not documented.

Health Benefits

• May inhibit cancer cell proliferation (preliminary evidence from in vitro studies on prostate cancer cells)
• Exhibits antioxidant activity by inhibiting oxygen radical formation and enhancing Fe²⁺ oxidation (mechanistic studies only)
• Inhibits ornithine decarboxylase, a key enzyme in polyamine biosynthesis (biochemical evidence)
• Traditionally used for anti-inflammatory and antibacterial purposes (historical use, no clinical trials)
• May support antiviral activity (traditional use claims, no human studies available)

How It Works

Baicalein inhibits ornithine decarboxylase, a rate-limiting enzyme in polyamine biosynthesis that regulates cell proliferation and cancer development. The compound exhibits antioxidant activity by scavenging oxygen radicals and enhancing Fe²⁺ oxidation through electron donation. It may also modulate various signaling pathways involved in apoptosis and cell cycle regulation in cancer cells.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically for baicalein were identified in the available research. The evidence is limited to in vitro and animal model studies, with some indirect observations from PC-SPES herbal extracts containing baicalin (baicalein's precursor) for prostate cancer applications.

Clinical Summary

Current evidence for baicalein is limited to preliminary in vitro studies and mechanistic research. Laboratory studies on prostate cancer cells have shown inhibition of cell proliferation, though specific sample sizes and quantified outcomes are not widely reported. Mechanistic studies demonstrate measurable antioxidant activity through radical scavenging assays. Human clinical trials investigating therapeutic dosages and safety profiles are lacking, making clinical efficacy uncertain.

Nutritional Profile

Baicalein (5,6,7-trihydroxyflavone) is a pure flavonoid compound (molecular weight: 270.24 g/mol), not a whole food, and therefore carries no macronutrient, fiber, protein, or caloric profile in the conventional nutritional sense. Bioactive compound identity: 100% baicalein when in isolated/purified form. Naturally occurs in the root of Scutellaria baicalensis (Chinese skullcap) at concentrations of approximately 10–15% dry weight of the root extract, and in Scutellaria lateriflora at lower concentrations (~0.1–1% dry weight). Also found in smaller amounts in Oroxylum indicum seeds. As a pure aglycone flavonoid, it contains three hydroxyl groups at positions 5, 6, and 7 on the A-ring of the flavone backbone, which are directly responsible for its antioxidant and chelating activities (Fe²⁺ oxidation enhancement). Bioavailability: Baicalein is the aglycone form of baicalin (its glucuronide precursor); intestinal and hepatic metabolism converts baicalin to baicalein via β-glucuronidase enzymes in gut microbiota. Oral bioavailability of pure baicalein is relatively low (~2–4% in some animal studies) due to rapid phase II metabolism (glucuronidation and sulfation), first-pass hepatic metabolism, and poor aqueous solubility (~0.2 mg/mL in water). Peak plasma concentration (Cmax) reported in animal models at doses of 50 mg/kg reaches approximately 0.5–2 µg/mL. Lipophilicity (logP ≈ 2.4) allows moderate membrane permeability. No vitamins, dietary minerals, or fiber content applicable. Co-administration with piperine or lipid-based formulations has been shown experimentally to enhance absorption.

Preparation & Dosage

No clinically studied dosage ranges for baicalein have been established due to absence of human trials. Preclinical studies used commercial baicalein at 98% purity, while herbal extracts like PC-SPES contained baicalin at approximately 6% of the ethanol-soluble fraction. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Baicalin, wogonin, quercetin, green tea extract, curcumin

Safety & Interactions

Safety data for baicalein supplementation in humans is limited due to lack of comprehensive clinical trials. Potential side effects and optimal dosing ranges have not been established through controlled studies. Drug interactions are poorly characterized, though flavonoids may theoretically affect cytochrome P450 enzyme activity. Pregnant and breastfeeding women should avoid baicalein supplements due to insufficient safety data.